Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Biosimilars

Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO) (HV475016)

Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)
Price(USD): $
Spec:
  • 100ug
  • 1mg
Number:
Contact us
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HV475016
Description
Ragifilimab (HV475016) is a research-grade recombinant antibody targeting CD357. Produced in mammalian cells with native-like glycosylation.
Highlights
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivityHuman
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host speciesHumanized
IsotypeIgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Activation-inducible TNFR family receptor, GITR, TNFRSF18, CD357, Tumor necrosis factor receptor superfamily member 18, AITR, Glucocorticoid-induced TNFR-related protein
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q9Y5U5
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background

Tumor necrosis factor receptor superfamily member 18 (CD357/GITR) is a ~26 kDa protein. Receptor for TNFSF18. Seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. Mediated NF-kappa-B activation via the TRAF2/NIK pathway.

Note For research use only. Not suitable for clinical or therapeutic use.
Images
  • Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)

    Bioactivity

    Detects CD357/TNFRSF18/GITR in indirect ELISAs.

  • Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)

    Flow CytoMetry

    Flow-cytometry using APC anti-human CD357 antibody. RPMI-8226 cells were stained with an irrelevant antibody (Blue Histogram) or an APC anti-human CD357 monoclonal antibody (Catalog: HV475016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)

    Flow CytoMetry

    Flow-cytometry using PE anti-human CD357 antibody. RPMI-8226 cells were stained with an irrelevant antibody (Blue Histogram) or an PE anti-human CD357 monoclonal antibody (Catalog: HV475016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)

    Western blot

    Western blot analysis was performed using anti-CD357/TNFRSF18/GITR monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human CD357/TNFRSF18/GITR (Catalog No: HV475011)
    Lane 2: negative control

  • Anti-Human GITR Ligand/TNFSF18 Reference Antibody (Ragifilimab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Ragifilimab

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list